标题
Brain cholesterol metabolism and Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 34, Issue 3, Pages 386-395
出版商
Wiley
发表日期
2019-01-26
DOI
10.1002/mds.27609
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The level of 24-hydroxycholesteryl esters decreases in plasma of patients with Parkinson’s disease
- (2018) Concetta Di Natale et al. NEUROSCIENCE LETTERS
- Low body mass index and life prognosis in Parkinson's disease
- (2018) Kwiyoung Park et al. PARKINSONISM & RELATED DISORDERS
- In vitrocytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds
- (2017) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
- (2017) Guodong Liu et al. MOVEMENT DISORDERS
- Comparative effect of statins on the risk of incident Alzheimer disease
- (2017) Liliya Sinyavskaya et al. NEUROLOGY
- Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)
- (2017) Natalia Mast et al. PLoS One
- Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress
- (2017) Camille B. Carroll et al. Journal of Parkinsons Disease
- Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
- (2017) Alastair J. Noyce et al. PLOS MEDICINE
- Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson’s Risk
- (2017) Lijun Zhang et al. Frontiers in Neurology
- Statin therapy prevents the onset of Parkinson disease in patients with diabetes
- (2016) Kun-Der Lin et al. ANNALS OF NEUROLOGY
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease
- (2016) Jae Jung Lee et al. NEUROBIOLOGY OF AGING
- Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson’s Disease
- (2016) Aging and Disease
- The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions
- (2015) Mechelle M. Lewis et al. JOURNAL OF NEUROLOGY
- The NINDS Parkinson's disease biomarkers program
- (2015) Liana S. Rosenthal et al. MOVEMENT DISORDERS
- Plasma fasting cholesterol profiles and age at onset in Parkinson's disease
- (2015) Philipp Mahlknecht et al. MOVEMENT DISORDERS
- 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
- (2015) Min-Yu Sun et al. NEUROSCIENTIST
- Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum
- (2014) Veera Venkata Ratnam Bandaru et al. BMC NEUROSCIENCE
- History of smoking and olfaction in Parkinson's disease
- (2014) Elisabeth B. Lucassen et al. MOVEMENT DISORDERS
- Epigenetic regulation of cholesterol homeostasis
- (2014) Steve Meaney Frontiers in Genetics
- Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort
- (2013) B. Mollenhauer et al. NEUROLOGY
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
- (2013) Ingemar Björkhem et al. NEUROSCIENCE LETTERS
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Oxysterols as biomarkers in neurodegenerative diseases
- (2011) Valerio Leoni et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
- (2011) Junqiang Yan et al. PLoS One
- Olfactory epithelial transplantation: possible mechanism for restoration of smell
- (2010) Richard M Costanzo et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Oxysterols as markers of neurological disease – a review
- (2009) Valerio Leoni SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Different Patterns of Oxidized Lipid Products in Plasma and Urine of Dengue Fever, Stroke, and Parkinson's Disease Patients: Cautions in the Use of Biomarkers of Oxidative Stress
- (2008) Chung-Yung J. Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Total cholesterol and the risk of Parkinson disease
- (2008) G. Hu et al. NEUROLOGY
- Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation
- (2008) T. Kotti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample
- (2007) Chung-Yung J. Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started